Eledon Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 2.4
| ELDN Stock | USD 4.46 0.20 4.29% |
Eledon |
Eledon Pharmaceuticals Target Price Odds to finish below 2.4
The tendency of Eledon Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 2.40 or more in 90 days |
| 4.46 | 90 days | 2.40 | about 11.27 |
Based on a normal probability distribution, the odds of Eledon Pharmaceuticals to drop to $ 2.40 or more in 90 days from now is about 11.27 (This Eledon Pharmaceuticals probability density function shows the probability of Eledon Stock to fall within a particular range of prices over 90 days) . Probability of Eledon Pharmaceuticals price to stay between $ 2.40 and its current price of $4.46 at the end of the 90-day period is about 71.78 .
Given the investment horizon of 90 days Eledon Pharmaceuticals has a beta of 0.11 suggesting as returns on the market go up, Eledon Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Eledon Pharmaceuticals will be expected to be much smaller as well. Additionally Eledon Pharmaceuticals has an alpha of 0.9585, implying that it can generate a 0.96 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Eledon Pharmaceuticals Price Density |
| Price |
Predictive Modules for Eledon Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eledon Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eledon Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eledon Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Eledon Pharmaceuticals is not an exception. The market had few large corrections towards the Eledon Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eledon Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eledon Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.96 | |
β | Beta against Dow Jones | 0.11 | |
σ | Overall volatility | 0.95 | |
Ir | Information ratio | 0.17 |
Eledon Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eledon Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eledon Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Eledon Pharmaceuticals is way too risky over 90 days horizon | |
| Eledon Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (40.33 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eledon Pharmaceuticals currently holds about 70.46 M in cash with (39.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Eledon Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Gros David-alexandre C of 1015743 shares of Eledon Pharmaceuticals at 2.3 subject to Rule 16b-3 |
Eledon Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Eledon Stock often depends not only on the future outlook of the current and potential Eledon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eledon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.6 M | |
| Cash And Short Term Investments | 51.1 M |
Eledon Pharmaceuticals Technical Analysis
Eledon Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Eledon Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Eledon Pharmaceuticals. In general, you should focus on analyzing Eledon Stock price patterns and their correlations with different microeconomic environments and drivers.
Eledon Pharmaceuticals Predictive Forecast Models
Eledon Pharmaceuticals' time-series forecasting models is one of many Eledon Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Eledon Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Eledon Pharmaceuticals
Checking the ongoing alerts about Eledon Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Eledon Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Eledon Pharmaceuticals is way too risky over 90 days horizon | |
| Eledon Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (40.33 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eledon Pharmaceuticals currently holds about 70.46 M in cash with (39.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Eledon Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Gros David-alexandre C of 1015743 shares of Eledon Pharmaceuticals at 2.3 subject to Rule 16b-3 |
Check out Eledon Pharmaceuticals Backtesting, Eledon Pharmaceuticals Valuation, Eledon Pharmaceuticals Correlation, Eledon Pharmaceuticals Hype Analysis, Eledon Pharmaceuticals Volatility, Eledon Pharmaceuticals History as well as Eledon Pharmaceuticals Performance. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.73 | Return On Assets (0.33) | Return On Equity (0.25) |
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.